Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1-Reference-Cited by-同舟云学术

Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1

Published:2021-06-24 Issue:6 Volume:9 Page:662-671
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Biewenga Maaike¹^ORCID,Verhelst Xavier P.D.M.J.²^ORCID,Baven‐Pronk Martine A.M.C.³,Putter Hein⁴,Berg Aad P.⁵,Nieuwkerk Karin C.M.J.⁶,Buuren Henk R.⁷,Bouma Gerd⁶,Boer Ynte S.⁶,Simoen Cedric²,Colle Isabelle⁸,Schouten Jeoffrey⁹,Sermon Filip¹⁰,Steenkiste Christophe¹¹¹²,Vlierberghe Hans²,Meer Adriaan J.⁷,Nevens Frederik¹³,Hoek Bart¹^ORCID,

Affiliation:

1. Department of Gastroenterology and Hepatology Leiden University Medical Center Leiden the Netherlands

2. Department of Gastroenterology and Hepatology UZ Ghent Ghent Belgium

3. Department of Gastroenterology and Hepatology Green Heart Hospital Gouda the Netherlands

4. Department of Biomedical Data Sciences Leiden University Medical Center Leiden the Netherlands

5. Department of Gastroenterology and Hepatology University Medical Center Groningen Groningen the Netherlands

6. Department of Gastroenterology and Hepatology Amsterdam University Medical Center location VUmc Amsterdam the Netherlands

7. Department of Gastroenterology and Hepatology Erasmus MC Rotterdam the Netherlands

8. Department of Gastroenterology and Hepatology ASZ Aalst Aalst Belgium

9. Department of Gastroenterology and Hepatology AZ Nikolaas Sint‐Niklaas Belgium

10. Department of Gastroenterology and Hepatology OLV Aalst Aalst Belgium

11. Department of Gastroenterology and Hepatology AZ Maria Middelares Ghent Ghent Belgium

12. Department of Gastroenterology and Hepatology University Hospital Antwerp Antwerp Belgium

13. Department of Gastroenterology and Hepatology UZ Leuven Leuven Belgium

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12112

Reference37 articles.

1. Auto immune hepatitis

2. Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

3. Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early Prognosis

4. CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS

5. Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial;Trials;2024-01-17

2. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis;Journal of Hepatology;2023-12

3. Tacrolimus versus mycophenolate for autoimmune hepatitis patients with incomplete response on first line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial;2023-11-20

4. Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry;Hepatology;2023-09-04

5. Development and validation of a noninvasive prediction model of autoimmune hepatitis in patients with liver diseases;Scandinavian Journal of Gastroenterology;2023-08-30